Kentucky Statutes 218A.025 – Controlled Substances Prescribing Council — Membership — Duties – Report
Current as of: 2024 | Check for updates
|
Other versions
(1) The Controlled Substances Prescribing Council is hereby established under the Office of the Inspector General. The council shall consist of the following fifteen (15) members:
(a) The Inspector General of the Cabinet for Health and Family Services, who shall serve as chair of the council;
(b) The executive director of the Office of Drug Control Policy;
(c) Two (2) currently licensed prescribers of scheduled drugs selected by the Kentucky Board of Dentistry, one (1) of whom shall be a dentist and one (1) of whom shall be an oral surgeon;
(d) Four (4) licensed physicians who currently prescribe scheduled drugs selected by the Kentucky Board of Medical Licensure, one (1) of whom shall have a specialty in primary care, one (1) of whom shall have a specialty in emergency medicine, one (1) of whom shall have a specialty in psychiatry or addiction medicine, and one (1) of whom shall have a specialty in pain management;
(e) Four (4) licensed advanced practice registered nurses who currently prescribe scheduled drugs selected by the Kentucky Board of Nursing, one (1) of whom shall have a specialty in primary care, one (1) of whom shall have a specialty in acute care, one (1) of whom shall have a specialty in psychiatric mental health or addiction, and one (1) of whom shall have a specialty in pain management;
(f) One (1) licensed prescriber of scheduled drugs selected by the Kentucky
Board of Optometric Examiners;
(g) One (1) licensed prescriber of scheduled drugs selected by the Kentucky
Board of Podiatry; and
(h) One (1) licensed pharmacist selected by the Kentucky Board of Pharmacy.
(2) The council shall meet at least quarterly to discuss matters relating to the safe and appropriate prescribing and dispensing of controlled substances, including:
(a) The review of quarterly reports issued by the Office of the Inspector General pursuant to KRS § 218A.202(9) to identify potential improper, inappropriate, or illegal prescribing or dispensing of controlled substances by examining aggregate patterns of prescribing by profession of the prescriber and county where the medication was prescribed and dispensed;
(b) Recommendations for improvements in data collection and reporting by the electronic system for monitoring controlled substances pursuant to KRS
218A.202;
(c) Recommendations for best prescribing practices based on up-to-date research; (d) Recommendations to the professional licensing boards for actions to aid in
enforcing current law, reviewing prescribing and dispensing data, and
correcting improper, inappropriate, or illegal prescribing or dispensing of a controlled substance; and
(e) Development and communication of any recommendations, based on review of data or research, to each licensure board. The licensure boards shall respond in writing to the panel within ninety (90) days of receiving the recommendations with an explanation of their response to the recommendations.
(3) The council may request information from the licensure boards regarding their procedures for conducting investigations and taking actions regarding the possible improper, inappropriate, or illegal prescribing or dispensing of controlled substances.
(4) On or before December 31, 2024, and each December 31 thereafter, the council shall submit an annual report to the Governor and the Legislative Research Commission. The annual report shall:
(a) List the council’s meeting dates and topics for the preceding year;
(b) Provide relevant statistical information, including a summary of the aggregate patterns by profession of prescriber and by county, of potential improper, inappropriate, or illegal prescribing or dispensing of a controlled substance;
(c) Describe the efforts made by the council to share information among the licensure boards related to improving the safe and appropriate prescribing and dispensing of controlled substances;
(d) Summarize responses received from the licensure boards to the panel’s
recommendations; and
(e) Provide any policy recommendations, including recommendations for statutory or administrative regulation changes intended to improve prescribing and dispensing practices and prevent improper, inappropriate, or illegal prescribing or dispensing of controlled substances.
(5) The council shall not make any recommendations related to the scope of practice of any prescribing or dispensing professionals.
(6) The council shall be attached to the Office of the Inspector General for administrative purposes.
(7) Members shall not receive any additional compensation for their service on the council but shall be reimbursed for all necessary expenses.
Effective: June 29, 2023
History: Created 2023 Ky. Acts ch. 73, sec. 2, effective June 29, 2023.
Legislative Research Commission Note (6/29/2023). 2023 Ky. Acts ch. 146, sec. 38, amended KRS § 218A.202 and renumbered the subsection referenced in subsection (2) of this section. Under the authority of KRS § 7.136(1), the Reviser of Statutes has made the necessary change to reflect the renumbered reference.
(a) The Inspector General of the Cabinet for Health and Family Services, who shall serve as chair of the council;
Terms Used In Kentucky Statutes 218A.025
- Cabinet: means the Cabinet for Health and Family Services. See Kentucky Statutes 218A.010
- Drug: means :
(a) Substances recognized as drugs in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them. See Kentucky Statutes 218A.010 - Pharmacist: means a natural person licensed by this state to engage in the practice
of the profession of pharmacy. See Kentucky Statutes 218A.010 - Year: means calendar year. See Kentucky Statutes 446.010
(b) The executive director of the Office of Drug Control Policy;
(c) Two (2) currently licensed prescribers of scheduled drugs selected by the Kentucky Board of Dentistry, one (1) of whom shall be a dentist and one (1) of whom shall be an oral surgeon;
(d) Four (4) licensed physicians who currently prescribe scheduled drugs selected by the Kentucky Board of Medical Licensure, one (1) of whom shall have a specialty in primary care, one (1) of whom shall have a specialty in emergency medicine, one (1) of whom shall have a specialty in psychiatry or addiction medicine, and one (1) of whom shall have a specialty in pain management;
(e) Four (4) licensed advanced practice registered nurses who currently prescribe scheduled drugs selected by the Kentucky Board of Nursing, one (1) of whom shall have a specialty in primary care, one (1) of whom shall have a specialty in acute care, one (1) of whom shall have a specialty in psychiatric mental health or addiction, and one (1) of whom shall have a specialty in pain management;
(f) One (1) licensed prescriber of scheduled drugs selected by the Kentucky
Board of Optometric Examiners;
(g) One (1) licensed prescriber of scheduled drugs selected by the Kentucky
Board of Podiatry; and
(h) One (1) licensed pharmacist selected by the Kentucky Board of Pharmacy.
(2) The council shall meet at least quarterly to discuss matters relating to the safe and appropriate prescribing and dispensing of controlled substances, including:
(a) The review of quarterly reports issued by the Office of the Inspector General pursuant to KRS § 218A.202(9) to identify potential improper, inappropriate, or illegal prescribing or dispensing of controlled substances by examining aggregate patterns of prescribing by profession of the prescriber and county where the medication was prescribed and dispensed;
(b) Recommendations for improvements in data collection and reporting by the electronic system for monitoring controlled substances pursuant to KRS
218A.202;
(c) Recommendations for best prescribing practices based on up-to-date research; (d) Recommendations to the professional licensing boards for actions to aid in
enforcing current law, reviewing prescribing and dispensing data, and
correcting improper, inappropriate, or illegal prescribing or dispensing of a controlled substance; and
(e) Development and communication of any recommendations, based on review of data or research, to each licensure board. The licensure boards shall respond in writing to the panel within ninety (90) days of receiving the recommendations with an explanation of their response to the recommendations.
(3) The council may request information from the licensure boards regarding their procedures for conducting investigations and taking actions regarding the possible improper, inappropriate, or illegal prescribing or dispensing of controlled substances.
(4) On or before December 31, 2024, and each December 31 thereafter, the council shall submit an annual report to the Governor and the Legislative Research Commission. The annual report shall:
(a) List the council’s meeting dates and topics for the preceding year;
(b) Provide relevant statistical information, including a summary of the aggregate patterns by profession of prescriber and by county, of potential improper, inappropriate, or illegal prescribing or dispensing of a controlled substance;
(c) Describe the efforts made by the council to share information among the licensure boards related to improving the safe and appropriate prescribing and dispensing of controlled substances;
(d) Summarize responses received from the licensure boards to the panel’s
recommendations; and
(e) Provide any policy recommendations, including recommendations for statutory or administrative regulation changes intended to improve prescribing and dispensing practices and prevent improper, inappropriate, or illegal prescribing or dispensing of controlled substances.
(5) The council shall not make any recommendations related to the scope of practice of any prescribing or dispensing professionals.
(6) The council shall be attached to the Office of the Inspector General for administrative purposes.
(7) Members shall not receive any additional compensation for their service on the council but shall be reimbursed for all necessary expenses.
Effective: June 29, 2023
History: Created 2023 Ky. Acts ch. 73, sec. 2, effective June 29, 2023.
Legislative Research Commission Note (6/29/2023). 2023 Ky. Acts ch. 146, sec. 38, amended KRS § 218A.202 and renumbered the subsection referenced in subsection (2) of this section. Under the authority of KRS § 7.136(1), the Reviser of Statutes has made the necessary change to reflect the renumbered reference.